Definiens is the leading provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived from other sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and supports better decisions in research, diagnostics and therapy. Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients’ lives.
Definiens’ software frees clinicians and scientists from poring over images, enabling them to focus on the critical work of investigation and interpretation:
As the amount of image data grows exponentially, automation of image and data analysis is the only way to reduce the information bottleneck. Definiens’ revolutionary technology provides unprecedented accuracy in identifying and quantifying biological attributes within images and turning them into knowledge.
Definiens is headquartered in Munich, Germany, and has a North American office in Carlsbad, California.